Welcome to the Obesity & Metabolic Innovation Forum
We are thrilled to announce the launch of the Obesity & Metabolic Innovation Forum (December 4-5), the only conference dedicated to providing a holistic roadmap to transform weight loss and cardiometabolic drug infrastructure.
Join us for this inaugural event where pharmaceutical companies, biotechs, payers, and providers come together to drive innovation, foster partnerships, and enhance access to effective obesity and metabolic health treatments. With a sharp focus on GLP-1s, we will explore the business dynamics behind this groundbreaking modality and its significant impact on the health industry.
2
full days of content
25+
industry leading speakers
100+
industry experts
10+
dedicated networking hours
Key Topics Covered
Our conference features insights from top companies and thought leaders, tackling the most pressing issues and trends in obesity and metabolic health.
Transforming Obesity & Metabolic Health
Gain an overview of current obesity and metabolic disorder treatments, focusing on unmet needs and challenges. Explore breakthroughs in incretin-based therapies, future trends in precision medicine, and digital health. Learn how to navigate regulatory and market access challenges for broader, equitable access to innovative treatments.
Market Access & Cost Containment
Meet with payers to explore cost containment strategies like drug discounting and competition. Learn to use outcomes data for strong health economic arguments, and explore innovative market access approaches, including "beyond the pill" solutions. Gain actionable insights to manage costs and enhance treatment access.
Expanding the Therapeutic Horizons of GLP-1 Drugs
Explore the expanded use of GLP-1 drugs beyond diabetes and obesity, supported by evidence in cardiovascular, renal, neurological, and hepatic health. Discuss future potential and research, and stay updated on the latest therapeutic applications to enhance clinical practice.
Regulatory Challenges
Understand the regulatory complexities for obesity drugs, including clinical trial challenges and agency roles. Discuss ethical considerations like long-term safety and public health strategies. Navigate the regulatory landscape to improve trial outcomes and ensure ethical drug development.
Companies in our Community
PARTNER WITH US
Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories:
Thought Leadership, Branding, and Networking.
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]
Contact us about the Obesity & Metabolic Innovation Forum
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.